189 related articles for article (PubMed ID: 15628853)
1. The crystal structure of Mycobacterium tuberculosis thymidylate kinase in complex with 3'-azidodeoxythymidine monophosphate suggests a mechanism for competitive inhibition.
Fioravanti E; Adam V; Munier-Lehmann H; Bourgeois D
Biochemistry; 2005 Jan; 44(1):130-7. PubMed ID: 15628853
[TBL] [Abstract][Full Text] [Related]
2. Structural basis for the efficient phosphorylation of AZT-MP (3'-azido-3'-deoxythymidine monophosphate) and dGMP by Plasmodium falciparum type I thymidylate kinase.
Whittingham JL; Carrero-Lerida J; Brannigan JA; Ruiz-Perez LM; Silva AP; Fogg MJ; Wilkinson AJ; Gilbert IH; Wilson KS; González-Pacanowska D
Biochem J; 2010 May; 428(3):499-509. PubMed ID: 20353400
[TBL] [Abstract][Full Text] [Related]
3. Potentiating AZT activation: structures of wild-type and mutant human thymidylate kinase suggest reasons for the mutants' improved kinetics with the HIV prodrug metabolite AZTMP.
Ostermann N; Lavie A; Padiyar S; Brundiers R; Veit T; Reinstein J; Goody RS; Konrad M; Schlichting I
J Mol Biol; 2000 Nov; 304(1):43-53. PubMed ID: 11071809
[TBL] [Abstract][Full Text] [Related]
4. Mycobacterium tuberculosis thymidylate kinase: structural studies of intermediates along the reaction pathway.
Fioravanti E; Haouz A; Ursby T; Munier-Lehmann H; Delarue M; Bourgeois D
J Mol Biol; 2003 Apr; 327(5):1077-92. PubMed ID: 12662932
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure of yeast thymidylate kinase complexed with the bisubstrate inhibitor P1-(5'-adenosyl) P5-(5'-thymidyl) pentaphosphate (TP5A) at 2.0 A resolution: implications for catalysis and AZT activation.
Lavie A; Konrad M; Brundiers R; Goody RS; Schlichting I; Reinstein J
Biochemistry; 1998 Mar; 37(11):3677-86. PubMed ID: 9521686
[TBL] [Abstract][Full Text] [Related]
6. Structural basis for efficient phosphorylation of 3'-azidothymidine monophosphate by Escherichia coli thymidylate kinase.
Lavie A; Ostermann N; Brundiers R; Goody RS; Reinstein J; Konrad M; Schlichting I
Proc Natl Acad Sci U S A; 1998 Nov; 95(24):14045-50. PubMed ID: 9826650
[TBL] [Abstract][Full Text] [Related]
7. Structural requirements for efficient phosphorylation of nucleotide analogs by human thymidylate kinase.
Lavie A; Konrad M
Mini Rev Med Chem; 2004 May; 4(4):351-9. PubMed ID: 15134538
[TBL] [Abstract][Full Text] [Related]
8. Structures of human thymidylate kinase in complex with prodrugs: implications for the structure-based design of novel compounds.
Ostermann N; Segura-Peña D; Meier C; Veit T; Monnerjahn C; Konrad M; Lavie A
Biochemistry; 2003 Mar; 42(9):2568-77. PubMed ID: 12614151
[TBL] [Abstract][Full Text] [Related]
9. Structure of thymidylate kinase reveals the cause behind the limiting step in AZT activation.
Lavie A; Vetter IR; Konrad M; Goody RS; Reinstein J; Schlichting I
Nat Struct Biol; 1997 Aug; 4(8):601-4. PubMed ID: 9253404
[No Abstract] [Full Text] [Related]
10. X-ray structure of TMP kinase from Mycobacterium tuberculosis complexed with TMP at 1.95 A resolution.
Li de la Sierra I; Munier-Lehmann H; Gilles AM; Bârzu O; Delarue M
J Mol Biol; 2001 Aug; 311(1):87-100. PubMed ID: 11469859
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of carbocyclic nucleotides as potential substrates for thymidylate kinase.
Ludek OR; Meier C
Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):683-6. PubMed ID: 16248014
[TBL] [Abstract][Full Text] [Related]
12. Novel nucleotide analogues as potential substrates for TMPK, a key enzyme in the metabolism of AZT.
Müller HC; Meier C; Balzarini J; Reinstein J
Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):821-3. PubMed ID: 14565287
[TBL] [Abstract][Full Text] [Related]
13. Comparative study of purine and pyrimidine nucleoside analogues acting on the thymidylate kinases of Mycobacterium tuberculosis and of humans.
Pochet S; Dugué L; Labesse G; Delepierre M; Munier-Lehmann H
Chembiochem; 2003 Aug; 4(8):742-7. PubMed ID: 12898625
[TBL] [Abstract][Full Text] [Related]
14. Modifying human thymidylate kinase to potentiate azidothymidine activation.
Brundiers R; Lavie A; Veit T; Reinstein J; Schlichting I; Ostermann N; Goody RS; Konrad M
J Biol Chem; 1999 Dec; 274(50):35289-92. PubMed ID: 10585390
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of dTTP inhibition of the bifunctional dCTP deaminase:dUTPase encoded by Mycobacterium tuberculosis.
Helt SS; Thymark M; Harris P; Aagaard C; Dietrich J; Larsen S; Willemoes M
J Mol Biol; 2008 Feb; 376(2):554-69. PubMed ID: 18164314
[TBL] [Abstract][Full Text] [Related]
16. Structure-based in-silico rational design of a selective peptide inhibitor for thymidine monophosphate kinase of mycobacterium tuberculosis.
Kumar M; Sharma S; Srinivasan A; Singh TP; Kaur P
J Mol Model; 2011 May; 17(5):1173-82. PubMed ID: 20697760
[TBL] [Abstract][Full Text] [Related]
17. 3'-Azido-3'-deoxythymidine-(5')-tetraphospho-(5')-adenosine, the product of ATP-mediated excision of chain-terminating AZTMP, is a potent chain-terminating substrate for HIV-1 reverse transcriptase.
Dharmasena S; Pongracz Z; Arnold E; Sarafianos SG; Parniak MA
Biochemistry; 2007 Jan; 46(3):828-36. PubMed ID: 17223704
[TBL] [Abstract][Full Text] [Related]
18. Crystal structure of the pantothenate synthetase from Mycobacterium tuberculosis, snapshots of the enzyme in action.
Wang S; Eisenberg D
Biochemistry; 2006 Feb; 45(6):1554-61. PubMed ID: 16460002
[TBL] [Abstract][Full Text] [Related]
19. Structure of shikimate kinase from Mycobacterium tuberculosis reveals the binding of shikimic acid.
Pereira JH; de Oliveira JS; Canduri F; Dias MV; Palma MS; Basso LA; Santos DS; de Azevedo WF
Acta Crystallogr D Biol Crystallogr; 2004 Dec; 60(Pt 12 Pt 2):2310-9. PubMed ID: 15583379
[TBL] [Abstract][Full Text] [Related]
20. AZT monophosphate knocks thymidylate kinase for a loop.
Kenyon GL
Nat Struct Biol; 1997 Aug; 4(8):595-7. PubMed ID: 9253402
[No Abstract] [Full Text] [Related]
[Next] [New Search]
